Results 91 to 100 of about 27,405 (227)

Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07

, 1992
Miljenko V. Pilepich, John M. Krall, Madhu J. John, P. Rubin, D.G. McGowan, Víctor A. Marcial   +5 more
openalex   +1 more source

Bone marrow augmentation in renal transplant recipients [PDF]

, 1998
Aitouche, Barber, Billingham, Demetris, Fontes, Garcia-Morales, Ildstad, Iyengar, McDaniel, Monaco, Monaco, Monaco, Monaco, Monaco, Najarian, Quesenberry, R Shapiro, Rao, Rao, Rao, Rao, Ricordi, Shapiro, Shapiro, Slavin, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Strober, T.E Starzl, Thomas, Thomas, Wood, Wood, Zinkernagel, Zinkernagel, Zinkernagel   +39 more
core   +1 more source

Secondary Cytoreduction Versus Chemotherapy Alone in the Treatment of Patients with Recurrent Ovarian Cancer: Is a Randomized Trial Worthwhile? [PDF]

, 2013
Paolo Sammartino, Daniele Biacchi, Marialuisa Framarino‐dei‐Malatesta   +2 more
openalex   +1 more source

RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate

, 2000
Gerald E. Hanks, Jiandong Lu, Mitchell Machtay, V.M. Venkatesan, Wayne H. Pinover, Roger W. Byhardt, Seth A. Rosenthal   +6 more
openalex   +1 more source

Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide

, 2000
R. Duerst, JT Horan, JL Liesveld, CN Abboud, LM Zwetsch, ES Senf, LS Constine, RF Raubertas, JA Passarell, JF DiPersio   +9 more
openalex   +1 more source

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.

The Lancet Oncology, 2017
R. Coleman, M. Brady, T. Herzog, P. Sabbatini, D. Armstrong, Joan L. Walker, Byoung-Gie Kim, K. Fujiwara, K. Tewari, D. O’Malley, S. Davidson, S. Rubin, P. DiSilvestro, K. Basen-Engquist, Helen Q. Huang, J. Chan, N. Spirtos, R. Ashfaq, R. Mannel   +18 more
semanticscholar   +1 more source

Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera? [PDF]

, 2016
Aziz Nazha, Aaron T. Gerds
openalex   +1 more source

Abstract B64: Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation. [PDF]

, 2016
Zhenqiu Liu, Jessica A. Beach, Hasmik Agadjanian, Dongyu Jia, Paul‐Joseph Aspuria, Beth Y. Karlan, Sandra Oršulić   +6 more
openalex   +1 more source

Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre [PDF]

, 2017
Anuradha Chandramohan, Andrew Thrower, Nehal Shah, Faheez Mohamed   +3 more
openalex   +1 more source

Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer [PDF]

, 2017
Simon Ducoulombier, François Golfier, Olivier Colomban, David Benayoun, Pierre‐Adrien Bolze, Michel Tod, Benoît You   +6 more
openalex   +1 more source